R o s u b Using ANOVA, Significantly lower levels of NAA/ Cho and N M C r and significantly higher levels of Cho/Cr were observed across both gray and white matter voxels in subjects with AD. Using individual Student's t tests, a significantly lower level of N M C h o and a higher level of Cho/Cr were observed in the posterior gray matter in subjects with AD. Using ANOVA in subjects with SIVD, significantly lower gray and white matter NAA/Cr levels were observed. Using Tukey's test, the NAA/Cr level was significantly lower in frontal white matter voxels in subjects with SlVD compared with controls.
Conclusions: Our findings in subjects with AD suggest neuron loss in gray matter, axon loss in white matter, and altered Cho metabolism in posterior brain regions. Our findings in subjects with SIVD are consistent with higher levels of creatine-containing metabolites and/or lower levels of NAA in frontal white matter.
(Arch Neurol. 1996;53:167-174) S UBCORTlCAL 1SCHEMIC VaSCUlar dementia (SIVD) and Alzheimer's disease (AD) are conceptualized as separate disorders caused by &tinct pathological p r o c b ; however, the relative roles of subcortical and cortical events in AD and SIVD are not well understood. Dementia in subjects with AD is associated with loss of larger cortical neurons in the frontal, parietal, and temporal lobes, as well as in the hippocampus.'*2 This neuron loss is accompanied by the appearance of senile plaques and neurofibrillary tangles. Studies of cerebral blood flow in patients with AD find changes in function in the parietal and temporoparietal region^.^.^ In comparison, dementia in subjectswith SIVD is hypothesized to be caused by a loss or disruption of subcortical neurons leading to a disconnection of cortical neurons from subcortical structures. Subcortical ischemic vascular dementia is most commonly associated with subcortical lacunae and white matter signal hyperintensities (WMSHs) . In necropsy studies of patients with ischemic vascular disease, lacunar infarcts are most commonly found in frontal white matter adjacent to the anterior horns of the lateral ventricles, in the caudate nuclei, and in the putamen? These regions are believed to be vulnerable to infarction because they are supplied exclusively by small, high-
SUBJECTS AND METHODS

SUBJECTS
Subjects with AD and SIVD were referred from the University of California at San Francisco Memory and Alzheimer Center. All procedures were approved by the university's Committee on Human Research and all subjects or their guardian provided informed consent. Elderly controls were referred from themedid practices of collaboratinggeriatrichsandrecruited by posting fliers at senior citizens centers. All subjects were screened for the following: (1) major medical illnesses such as hypertension, heart disease, and diabetes; (2) major neurological illnesses, suchascorticalstroke, headinjurywith loss of consciousness, seizure disorder, and Parkinson's disease; (3) alcohol or drug abuse; and (4) major psychiatric illness, such as bipolar disorder or psychosis. Forty elderly subjects participatedsuccessfully in the MRSI study. They included 14 patients with AD (six men, eight women; mean age [?SD], 7227years; agerange, 59 to82years),eightpatientswithSIVD (three men, five women; mean age [ S D ] , 7329 years; age range, 51 to80years),and 18elderlycontrolsubjects (11 men, seven women; mean age [ 2 SD] ,70 2 5 years; age range, 6 1 to 80 years). Data from eight of the subjects with AD and 10 of the control subjects were reported previously."."
All 14subjectswithADmet the NationallnstituteofNeurological Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria for probable AD. Three subjects with AD were receiving thyroid replacement treatment, three had a history of hypertension, and two were receiving antihypertensive medications, although all were normotensive at the time of the procedure. One subject was taking buproprion for depression. Mean (2SD) MMSE'* score for 13 of the 14 subjects with AD was 1459, with a range of 0 to 28(one patient with mild probable AD had a MMSE score of 28; this patient's diagnosis was based on a gradual, welldocumented decline in psychosocial functioning). One subject with AD was too impaired to complete the test.
Eight subjects were diagnosed with SIVD using the criteria of Chui et all3 that require decline in two or more areas of intellectual performance and evidence on magnetic resonance imaging (MRI) ofat least one infarct outside of the cerebellum. Four subjectswith SIVD had hypertension, three had diabetes, and two had treated thyroid disease. Subjects with cortical strokes were excluded. Mean (2SD) MMSE score for the subjects with SIVD was 18.627, with a range of 5 to 27.
Eighteen elderly control subjects were screened as described above. One control subject was receiving thyroid replacement therapy, one had mild hypertension, and one had a prior diagnosis of lupus erythematosus that did not involve the central nervous system. All elderly controls scored 28 or more on the MMSE (mean [2SD] score, 2920.8).
When necessary subjects were sedated with 5 to 10 mg diazepam orally or 0.5 to 2 mg lorazepam sublingually for the magnetic resonance examination. Lorazepam was the preferred agent because of its rapid onset when given sublingually and its shorter half-life. Heart rate and oxygen saturation were monitored during the magnetic resonance procedures using a pulse oximeter. Twelve of 14 subjects with AD, eight of eight subjects with SIVD, and five of 18 controls required sedation. Although the use of sedation varied among the three groups, benzodiazepines are not known to affect 'H MRSI metabolites. We previously demonstrated that 20 mg of diazepam had no effect on cerebral magnetic resonance spectroscopic metabolites radioactively labeled with phosphorus 31.14 MAGNETIC RESONANCE All magnetic resonance studies were performed on a wholebody 2-T MRI and magnetic resonance spectroscopic system (Philips Medical Systems, Shelton, Conn). The procedures for MRI and 'H MRSI were the same as previously described.IO Briefly, magnetic resonance slices were angulated along the canthomeatal line. Nineteen to 23 contiguous sections of 5.1-mm thickness and 0.5-mm section gap repetition time, 3000 milliseconds; echo time, 30 and 80 milliseconds were obtained to cover the entire brain from cerebellum to vertex. The magnetic resonance images were qualitatively evaluated by a board certified neuroradiologist (D.N.) blinded to each subject's diagnosis. Ventricular dilatation and sulcal widening were each rated as follows: 0, absent; 1, mild 2, moderate; and 3, severe. Similarly, WMSHs were rated as follows: 0, absent; 1, limited to the tips of the horns of the lateral ventricles and/or periventricular rims; 2, small focal WMSHs in subependymal or subcortical regions; and 3, large or coalescing lesions. After MRI, a 17-mm-thick volume of interest corresponding in location and thickness to the three MRI slices immediately superior to the lateral ventricles was selected for 'H MRSI. The anterior-posterior and left-right dimensions of the 'H MRSI volume of interest were adjusted for every subject according to brain size (typically about 100 by 80 mm, respectively). 'H magnetic resonance spectroscopic imaging (MRSI) provides regional measures of (1) the amino acid N-acetylaspartate (NAA), a putative marker of neurons; (2) creatine (Cr) representing the sum of Cr plus phosphocreatine; and (3) choline-containing metabolites (Cho) representing primarily glycerophosphocholine and phosphocholine. We previously reported on 'H MRSI differences in eight patients with probable AD compared with 10 age-matched elderly controls.'O In that study, we found significantly lower levelsofNMChoandNANCrinwhitematterinsubjectswith AD and significantly lower levels of NAA/Cho and significandy higher levels of ChdCr in posterior gray matter of subjects with AD compared with elderly controls. findings in subjects with AD to a larger cohort and to compare these differences with findings from a group of subjects with SIVD. Our first a priori hypothesis was that gray matter and white matter N M C h o and NAA/Cr levels would belowerinsubjectswithADcomparedwithconhols, whereas in subjectswith SIVD, only differences in white matter metabolites would be observed. Our second a priori hypothesis was that metabolite differences in posterior (parietal) white matter regions would be detectable in subjects with AD compared with controls, whereas frontal white matter changes would be more prominent in subjects with SIVD. 
DATA PROCESSING
The data 'H MRSI and transverse MRI were analyzed using home-written spectroscopic imaging display software. 15 The M E 1 spectral dimension was zero filled to 1024 points. Both spatial dimensions were zero filled to 32 points so that 32 spectra were obtained along each of the spatial dimensions across the field of view. For display purposes only, spectroscopic images were further zero filled to 64 in each spatial dimension. A 1-Hz exponential line broadening was applied in the time domain. For both spatial domains, a mild gaussian multiplication was used corresponding to a broadening of approximately 1 mm and resulting in a final effective voxel size of approximately 2.5 mL. After Fourier transformation in spectral and spatial dimensions, two-dimensional MRSIs were created by integration over selected regions of the magnitude spectra.
For selection of the voxels to be analyzed, the spatially correlated summed MRI (composed of three thin MRI sections) was used exclusively. Spectra were extracted from nine voxels within the preselected volume of interest outlined on the MRI. The typical location and sue of the analyzed voxels are indicated on the transverse summed MRI shown in Figure 1 , B. Since AD primarily affects cortical gray matter, it would be desirable to select voxels largely containing superficial cortex. However, because of technical limitations, point-resolved spatially localized spectroscopy volume selection does not permit sampling of superficial cortex. To sample mesial cortex, three voxels from the midline area of the brain (one from the anterior mesial cortex, one from the posterior mesial cortex, and one from an intermediate region) were selected to include as much gray matter as possible while avoidingwhite matter tissue. It is recognized that these mesialvoxels contain significant amounts of cerebrospinal fluid. However, since cerebrospinal fluid does not contain significant amounts of the metabolites measured by 'H MRSI, variable contribution of cerebrospinal fluid to thevoxel volume shouldnot affect metabolite ratios. Six lateral voxels were selected (two each in the anterior, medial, and posterior regions) so they contained a maximum of white matter tissue (appearing relatively dark on the T2-weighted MRI), avoiding large sulci.
The nine extracted magnitude spectra were then transferred to a workstation equipped with software (NMRl, New Methods Research Inc, Syracuse, NY) for automated line fitting and peak area determination. Following manual setting of the baseline midway through the noise, three gaussian peaks were fitted to the three major resonances in the spectra originating from Cho, from Cr, and from N-acetyl groups, predominantly NAA. The peaks were fitted with gaussian rather than lorentzian lines because they are due to multiple compounds, and spectral residuals after line fitting were smaller with gaussian line shapes. Peak areas were derived from the NMRl software (New Methods Research Inc) in arbitrary units; no intensity standard was included in the studies. Since absolute peak areas are affected by possible long-term spectrometer instabilities and atrophy in the analyzed voxel, peak area ratios (NAAICho, NAA/Cr, and ChdCr) were used for primary data analysis.
STATISTICAL ANALYSIS
The 'H MRSl data analyses were perfomed by one of us (G.F.) using repeated measures analysis of variance (ANOVA) implemented in the general linear model procedure of the Statistical Analysis System software. The repeated measures were obtained from the nine spectra. Repeated measures ANOVA investigated differences between groups (ie, controls vs AD vs SIVD), between tissue types (ie, gray vs white matter), and between regions (ie, frontal vs posterior). For effects involving multiple repeated measures that were significant by ANOVA, Tukey's test was used to compare individual metabolite ratios between groups. Although we hypothesized group by region effects (eg, differences in frontal metabolites between groups) or group by tissue-type differences (eg, differences in white matter metabolites between groups), in some analyses only between-group differences were found, meaning that, eg, metabolite Merences existedbetween subjects with AD and controls, but they were the same in the gray matter and the white matter. These findings were reported as combined gray plus white matter differences. Individual Student's t tests were used when comparing posterior mesial gray matter metabolites between subjects with AD vs controls, since only two groups were compared on a single variable. The MRI findings were compared between groups using Tukey's test. The relationship between MRSI findings and dementia scores was tested using linear regression. All values are expressed as means5Ds and a P value of less than .05 was considered statistically significant .
Our h r d a priori hypothesis was that regional or tissue metabolite differences observed in subjects with AD and subjects with SIVD would occur in proportion to degree of dementia as determined by the Mini-Mental State examination (MMSE) .
OVERALL DIFFERENCES IN GRAY AND WHITE MATTER
Our first a priori hypothesis was that, over all nine voxels, NAA/Cho and N M C r levels would be lower in subjects with AD compared with controls; while in subjects with SIVD, only metabolite differences in the bilateral white matter would be observed (Tablo 1 1.
Comparing subjects with AD with controls, there was a main effect of group indicating significantly lower levels of N M C h o (P=.OOl) and N M C r (P=.02) and a significantly higher level of Cho/Cr (P=.02) in subjects with AD. We observed no group by tissue-type interaction, indicating that these differences were comparable in the gray and white matter voxels. In Table 1 , these are indicated as gray matter plus white matter differences.
Comparing the SIVD group with controls, we found a main effect indicating sigtuficandy lower levels of N M C r in subjects with SIVD across all nine voxels (P=.03). An analysis of group by tissue interaction was not significant (P=.12), however, this result suggested that the difference between groups might be greater in the white matter volumes. This was supported by Tukey's test, which found significant (P<.05) differences in levels of NAA/Cr between subjects with SIVD and controls only in the white matter.
ARCH
REGIONAL WHITE MATTER EFFECTS
Our second a priori hypothesis was that metabolite differences in posterior (parietal) white matter regions would be detectable in subjects with AD compared with controls, while frontal white matter changes would be more prominent in subjects with SIVD. 005) and N M C r (P=.O4) in subjects with AD across all six white matter voxels, consistent with the findings described for the first hypothesis. There was no significant group by region interaction.
To further investigate the effects of individual metabolites on regional metabolite ratios in subjects with AD, we compared the relative patterns of the metabolites in frontal, medial, and posterior white matter voxels using raw signal integrals. In subjects with AD, there was a trend toward a significant NAA region by group effect (P=.07) reflecting a relative reduction in white matter NAA level in subjects with AD, primarily in lower frontal white matter. A significant between-group difference in white matter Cho level was found (P=.05), with the A significant group by region (ie, front to back) effect was detected for NAA/Cr (P=.02), reflecting a relative reduction in the NAA/Cr level in frontal white matter voxels in subjects with SIVD vs controls ( frontal white matter voxels in subjects with SIVD. Taken together, these findings suggest a higher level of frontal Cr in subjects with SIVD compared with controls.
Regional raw metabolite integrals were compared within each subject as described above. A significant group by region effect was observed for Cr (P=.04), with no significant effects detected for Cho or NAA. This suggests that the between-group differences in NAA/Cr levels are due to differences in the frontal-posterior Cr gradient. Mean regional white matter NANCr results are displayed in Cigun 2. A scatterplot of frontal white matter NANCr levels is shown in Ciaun 3.
Subjects With AD vs With SIVD
A trend toward a group by region effect (P=.06) was seen for white matter NAA/Cho levels because of lower posterior white matter NANCho levels in subjects with AD. This finding is consistent with the hypothesis that brain effects are greater in the parietal white matter in subjects with AD than in medial or frontal white matter.
POSTERIOR GRAY MATTER DIFFERENCES
A post hoc hypothesis was generated from an analysis of data from the first five subjects with AD and seven controls that was published as an abstract." In that report, the NANCho level was significantly lower and the ChdCr level was significantly higher in the posterior mesial gray matter of subjects with AD vs controls. Following that analysis, an additional nine subjects with AD and 11 controls were recruited. Metabolite ratios from the posterior mesial gray matter of only these additional subjects are shown in Tabk 3. Significantly lower levels of N M Cho (P.<004) and significantly higher Cho/Cr levels (P=.004) were found in the posterior gray matter of subjects with AD compared with controls using Student's t tests with Bonferroni's correction for the two comparisons. This result confirms our earlier finding. A similar analysis was conducted using data from our SIVD cohort. Because SIVD appears to preferentially affect frontal white matter, our hypothesis was that no significant differences in posterior mesial gray matter metabolites would be seen between subjects with SIVD and controls (Tablo 4). The NAA/Cho level was significantly lower in the posterior mesial gray matter voxel in subjects with SIVD vs controls (P< .05), while the Cho/Cr level was significantly higher (Pc.02). Similar to the findings in subjects with AD, these results suggest a higher Cho signal in posterior gray matter in subjects with SIVD.
A comparison of metabolite levels between subjects with AD and SIVD for this region found significantly lower NAA/Cho levels in subjects with AD but no differences in the other metabolites. 
RELATIONSHIP OF MRSI AND QUALITATIVE MRI FINDINGS
The observation of 'H MRSI abnormalities in subjects with AD or SIVD compared with controls raised the possibility that metabolite Qfferences between groups could be related to MRI differences. Based on blinded qualitative analysis of MRI, significant differences in mean (t SD) ventricular dilatation (P< .os) were observedinsubjectswith AD (1. 
RELATIONSHIP OF MRSI AND DEMENTIA RATINGS
Our third a priori hypothesis was that regional or tissue metabolite differences observed in subjects with AD or SIVD would occur in proportion to the degree of dementia as de- termined by the MMSE. Analysis of the data revealed no significant correlations and no trends toward correlations of white matter or gray matter NANCho, N M C r , or Cho/Cr levels with MMSE scores in subjects with AD or SIVD.
Our primary findings were ( 1) lower levels of NAA/Cho and NAA/Cr and higher levels of Cho/Cr in both gray and white matter insubjectswith AD and (2) lower gray and whte matter N M C r levels in subjects with SIVD. In subjects with AD, the differences in Cho ratios were most prominent in posterior gray matter voxels. In subjects with SIVD, differences in N M C r levels were most prominent in frontal white matter voxels. The NAA is an amino acid found exclusively in neurons and their processes and not in glia. '6.17 The NAA signal appears specific for NAA in cortex, while N-acetylaspartylglutamate contributes slightly to the NAA peak in white matter. 18 have been reports of reversible decreases of NAA levels in multiple sclero~is'~ and carbon monoxide poisoning," implying that neurons were not killed in these cases but rather suffered reversible injury. Our finding of lower levels of N M C h o and N M C r in the gray and whte matter of subjects with AD is consistent, therefore, with loss or injury to cortical neurons and their axons. Lower NAA ratios have been reported in the temporal temporoparietal regions? parietal lobes,22*2s*26 and frontal lobe^^'.^^ using in vivo proton spectroscopy in subjects with AD. Our previous report found lower levels of N M C h o and N M C r in whte matter and lower levels of N M C h o and higher levels of CholCr in gray matter of subjects with AD compared with controls using an analysis based on individual Student's t tests. The current findings represent an extension of those findings to a larger cohort, although this is not a replication because subjects from the earlier report were included in our analysis. 0 ur finding of lower N M C h o and higher ChdCr levels in posterior gray and whte matter voxels in subjects with AD is consistent withalterationsinlevelsofchohecontaining metabolites that have been reported previously in postmortem studies of subjects with AD.ZS3' The Cho ddferences insubjectswith ADin thepresentstudyweremostprominentinposteriorpymtter. High numbers of senile piaques and neurofibrilhy tangles have been observed in this region along with neurodegeneration in an autopsy study of subjects with AD.32 It has been hypothesized that "auto-cannibalism'' of membrane bilayer phosphatidylcholine may occur in subjects with AD to provide Cho for production of acetylcholine.w Phosphatidylcholine is metabohzed to glycerophosphochohe (GPC) and thentophosphocholineandfreecholine. BothGPCandphosphocholine contribute significantly to the Cho peak in ' H MRSI and GPC contributes to the phosphodiester peak in j'P-magnetic resonance spectroscopy, while free choline and acetylcholine make much smaller contributions to the 'H MRSI Cho signal.33 Breakdown of membrane phospholipids could, therefore, cause an elevation in Cho and phosphodiester levels. Membrane bilayer phosphatidylcholine levels were reduced by 15% in a postmortem study of patients with AD.% Increases in GPC were also reported inpatients with AD.28 Enzyme kinetic studies support the idea that phosphatidylcholine catabolism rather than slowed metabohm of GPC are responsible for the higher levels of GPC in subjects with AD. 31 Elevation of phosphodiester levels have been shown to correlate with the numbers of senile plaques in tissue samples taken from frontal and temporoparietal regions of subjects with AD.34 These other authors proposed that the likely sequence of events is (1) degeneration of synapticprocases; (2) elevation of membrane phospholipid breakdown products; and (3) appearance of senile plaques. Elevated Cho signal in the gray matter in subjects with dementia may, therefore, provide an invivo marker for the appearance of senile plaques. Our findings of lower N M C h o and higher Cho/ Cr levels in subjects with AD are consistent with an elevation of membrane phospholipid breakdown products. Because our analysis of posterior mesial gray matter metabolites excluded subjects who were reported previously," this result is a replication of our earlier finding.
In contrast to the findings in subjects with AD, only the N M C r level was significantly lower in gray and white matter voxels in subjects with SIVD compared with controls. Regional analysis of the data suggests that the effect is strongest in the frontal white matter voxels. The frontal lobes have been shown previously to be one of the regions most affected in vascular dementia. 6 The finding of a lower N M C r level could be caused by a reduction in NAA or an elevation of creatine-containing metabolites. A lower level of NAA in white matter is consistent with loss or injury to axons. Lower levels of N M C r in subjects with SIVD correlated with measures of both ventricular and sulcal atrophy and suggest an association with volume loss. A lower level of NANCr could also be caused by higher Crcontaining metabolites in subjects with SIVD. Our analysis of the relationship between relative Cr signal in frontal, medial, and posterior white matter voxels in subjects with SIVD suggests that the slope of the anterior and posterior Cr gradient is significantly different in subjects with SIVD compared with controls, Higher levels of phosphocreatine have been reported in the frontal lobes of subjects with vascular dementia ~ing~'P-MRS1.3~ In that study, metabolite differences were detected in regions superficial to subcortical lesions such as the WMSHs. The authors speculated that this phenomenon might be due to increased g l d reactivity and disconnection of cortical neurons causing accumulation of intracellular high-energy phosphates. Since creatine and phosphocreatine are in dynamic equilibrium, however, an increase in phosphocreatine would not be expected to lead an alteration in the 'H MRSI Cr signal observed in this experiment.
The severity of WMSHs was significantly greater in the SIVD group than in either the AD or control groups. The WMSHs have been shown to be associated with 'H MRSI metabolite changes in elderly controls36 and in subjects with AD or SIVD (unpublished data, 1994). Our analysis of the relationship between ' H MRSI metabolite ratios and WMSH severity in subjects with SIVD revealed no significant correlations or trends, suggesting that the observed metabolite differences are not caused by greater WMSH load in the SIVD group.
Our study has several limitations. First is the difficulty of identifymg subjects with pure AD or SIVD using clinical diagnostic criteria. Without autopsy results, it is impossible to rule out the existence of degenerative changes in the SIVD cohort. Similarly, three of the subjects with AD had a history of hypertension and may have had some cerebrovascular damage, although all were normotensive at the time of study. A second limitation of our study is the failure to compare metabolite relaxation times between study groups, since the observed metabolite differences could be due solely to differences in metabolite TI-or T2-relaxation times rather thanaltered tissue concentmtions of metabolites. Relaxation times were not measured because of the long examination time required for these studies. Another study3' found no difference inT,-relaxation times between subjects with AD andcon~rok.Amorerecentst~d~~foundasig~uficantlylonger T2-relaxation time for NAA in a mixed gray and white matter volume from the frontal lobes of subjects with AD compared with controls while the T2-relaxation times for Cho and Cr were not different between groups. A longer NAA T2-relaxation time would lead to an apparent increase in the amount of NAA in the sample. This suggests that if the T2-relaxation time for NAA was similarly increased in our AD group, the NAA signal measures presented herein would be too high, which would increase the strength of our findings.
A third limitation is that the signal for each of the voxels in our study did not come entirely from gray or white matter. Signal from subcortical white matter contributed to mesial cortical gray matter signal and signal from sulcal gray matter contributed to white matter signal. As a result, eg, it is possible that metabolite differences in the white matter could give the appearance of significant differences in the gray matter. In subjects with AD, where the effect for the N M C h o level is greater in white matter than in gray matter, it is possible that the observed difference in the gray matter N M C h o level was influenced by the white matter difference. Definitive clarification of this issue requires determination of gray and white matter contribution to each of the nine voxels of each subject in the study by tissue segmentation of the MRI. The present analysis is the focus of future work by our group.
Not withstanding these limitations, the results of these measurements indicate that 'H MRSI detects regional and tissue-specific differences in both subjects with AD and those with SIVD compared with controls. These findings support in vitro and neuropathological findmgs in subjects with AD and those with SIVD and provide in vivo support for theories of disease effects in these dementias. 
